Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 218 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 4 results:
Author Title [ Type(Desc)] Year
Filters: Author is Barnett, A. H.  [Clear All Filters]
Journal Article
L. Watson, Das, R., Farquhar, R., Langerman, H., and Barnett, A. H., “Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database”, Curr Med Res Opin, vol. 32, pp. 1465-75, 2016.
S. H. Holden, Barnett, A. H., Peters, J. R., Jenkins-Jones, S., Poole, C. D., Morgan, C. L., and Currie, C. J., “The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010”, Diabetes Obes Metab, vol. 15, pp. 844-52, 2013.
C. L. Morgan, Jenkins-Jones, S., Evans, M., Barnett, A. H., Poole, C. D., and Currie, C. J., “Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs”, Diabetes Obes Metab, vol. 14, pp. 424-32, 2012.
C. L. Morgan, Poole, C. D., Evans, M., Barnett, A. H., Jenkins-Jones, S., and Currie, C. J., “What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes”, J Clin Endocrinol Metab, vol. 97, pp. 4605-12, 2012.
[Page last reviewed 5 January 2021]